Search

Amulet occluder shows promise against Watchman device in atrial fibrillation - European Society of Cardiology

pandangsa.blogspot.com

Notes to editor

ESC Press Office
Tel: +33 (0) 7 8531 2036
Email: press@escardio.org

Follow us on Twitter @ESCardioNews 

The hashtag for ESC Congress 2021 is #ESCCongress.

This press release accompanies both a presentation and an ESC press conference at ESC Congress 2021. It does not necessarily reflect the opinion of the European Society of Cardiology.

Funding: Funded by Abbott.

Disclosures: Consultant – Abbott, Acutus, Biotronik, Boston Scientific, Biosense Webster, Janssen and Medtronic.

References and notes

1Amulet IDE: Amplatzer Amulet left atrial appendage occluder randomised controlled trial.

2Ball J, Carrington MJ, McMurray JJV, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167:1807–1824.

3Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42:373–498.

4January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2019;74:104–132.

5Tzikas A, Holmes DR, Gafoor S, et al. Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies. Europace. 2017;19:4-15.

6Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864–2870.

7Lip GYH, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137:263–272.

About the European Society of Cardiology

The ESC brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.

About ESC Congress 2021 - The Digital Experience

It is the world’s largest gathering of cardiovascular professionals, disseminating ground-breaking science in a new digital format. Online each day – from 27 to 30 August. Explore the scientific programme. More information is available from the ESC Press Office at press@escardio.org.

Adblock test (Why?)



"device" - Google News
August 30, 2021 at 11:03AM
https://ift.tt/3h2Bk8D

Amulet occluder shows promise against Watchman device in atrial fibrillation - European Society of Cardiology
"device" - Google News
https://ift.tt/2KSbrrl
https://ift.tt/2YsSbsy

Bagikan Berita Ini

0 Response to "Amulet occluder shows promise against Watchman device in atrial fibrillation - European Society of Cardiology"

Post a Comment

Powered by Blogger.